Targeting Venetoclax Resistance in TP53-Mutated Acute Myeloid Leukemia

被引:0
|
作者
Vanttinen, Ida [1 ,2 ]
Ruokoranta, Tanja [1 ]
Saad, Joseph J. [1 ,2 ]
Kytola, Sari [3 ]
Hellesoy, Monica [4 ]
Gullaksen, Stein-Erik [4 ]
Ettala, Pia-Sofia [5 ]
Pyorala, Marja [6 ]
Rimpilainen, Johanna [7 ]
Siitonen, Timo [8 ]
Wennerberg, Krister [9 ]
Gjertsen, Bjorn T. [4 ,10 ]
Heckman, Caroline A. [1 ,2 ]
Kontro, Mika [1 ,2 ,3 ,11 ]
Kuusanmaki, Heikki [1 ,2 ,9 ,11 ]
机构
[1] Univ Helsinki, Inst Mol Med Finland FIMM, HiLIFE, Helsinki, Finland
[2] ICAN Digital Precis Canc Med Flagship, Helsinki, Finland
[3] Helsinki Univ Hosp, Dept Hematol, Comprehens Canc Ctr, Helsinki, Finland
[4] Helse Bergen, Hematol Sect, Dept Med, Bergen, Norway
[5] Turku Univ Hosp, Dept Clin Hematol, Turku, Finland
[6] Kuopio Univ Hosp, Dept Med, Kuopio, Finland
[7] Tampere Univ Hosp, Dept Internal Med, Tampere, Finland
[8] Oulu Univ Hosp, Canc Ctr, Hematol, Oulu, Finland
[9] Univ Copenhagen, Biotech Res & Innovat Ctr BRIC, Copenhagen, Denmark
[10] Univ Bergen, Dept Clin Sci, Ctr Canc Biomarkers CCBIO, Bergen, Norway
[11] Fdn Finnish Canc Inst, Helsinki, Finland
关键词
D O I
10.1182/blood-2023-189340
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Haploidentical haematopoietic stem cell transplantation for TP53-mutated acute myeloid leukaemia
    Huang, Ting
    Xu, Lanping
    Zhang, Xiaohui
    Chang, Yingjun
    Mo, Xiaodong
    Sun, Yuqian
    Huang, Xiaojun
    Wang, Yu
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 200 (04) : 494 - 505
  • [42] Prognostic and Therapeutic Implications of Mutant TP53 Variant Allelic Frequency in Adults with Newly Diagnosed TP53-Mutated Acute Myeloid Leukemia
    Short, Nicholas J.
    Montalban-Bravo, Guillermo
    Hwang, Hyunsoo
    Ning, Jing
    Franquiz, Miguel
    Kanagal-Shamanna, Rashmi
    Patel, Keyur
    Dinardo, Courtney D.
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Takahashi, Koichi
    Konopleva, Marina
    Daver, Naval
    Jabbour, Elias
    Yilmaz, Musa
    Issa, Ghayas C.
    Andreeff, Michael
    Kadia, Tapan M.
    BLOOD, 2020, 136
  • [43] FOLFOX resistance in TP53-mutated Metastatic Colorectal Cancer: mechanism and selective targeting
    Hollande, Frederic
    Behrenbruch, Corina
    Foroutan, Momeneh
    Simpson, Kaylene
    Heriot, Alexander
    CANCER SCIENCE, 2023, 114 : 739 - 739
  • [44] Eprenetapopt combined with venetoclax and azacitidine in TP53-mutated acute myeloid leukaemia: a phase 1, dose-finding and expansion study
    Garcia-Manero, Guillermo
    Goldberg, Aaron D.
    Winer, Eric S.
    Altman, Jessica K.
    Fathi, Amir T.
    Odenike, Olatoyosi
    Roboz, Gail J.
    Sweet, Kendra
    Miller, Crystal
    Wennborg, Anders
    Hickman, Denice K.
    Kanagal-Shamanna, Rashmi
    Kantarjian, Hagop
    Lancet, Jeffrey
    Komrokji, Rami
    Attar, Eyal C.
    Sallman, David A.
    LANCET HAEMATOLOGY, 2023, 10 (04): : E272 - E283
  • [45] Clinical outcomes and characteristics of patients with TP53-mutated acute myeloid leukemia or myelodysplastic syndromes: a single center experience*
    Bewersdorf, Jan Philipp
    Shallis, Rory M.
    Gowda, Lohith
    Wei, Wei
    Hager, Karl
    Isufi, Iris
    Kim, Tae Kon
    Pillai, Manoj M.
    Seropian, Stuart
    Podoltsev, Nikolai A.
    Gore, Steven D.
    Siddon, Alexa J.
    Zeidan, Amer M.
    LEUKEMIA & LYMPHOMA, 2020, 61 (09) : 2180 - 2190
  • [46] TP53-Mutated Acute Myeloid Leukemia and Blast Phase Myeloproliferative Neoplasm: Distinct Mutation Leads to Poorer Prognosis
    Chen, Dong
    Cantu, Miguel
    Siddon, Alexa
    Weinberg, Olga K.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025,
  • [47] DRP1 Inhibition Enhances Venetoclax-Induced Mitochondrial Apoptosis in TP53-Mutated Acute Myeloid Leukemia Cells through BAX/BAK Activation
    Jang, Ji Eun
    Hwang, Doh Yu
    Eom, Ju-In
    Cheong, June-Won
    Jeung, Hoi-Kyung
    Cho, Hyunsoo
    Chung, Haerim
    Kim, Jin Seok
    Min, Yoo Hong
    CANCERS, 2023, 15 (03)
  • [48] Prognostic Impact of Chromosomal Abnormalities in TP53-Mutated Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes
    Takeda, June
    Iwasaki, Makoto
    Kanda, Junya
    Nannya, Yasuhito
    Hiramoto, Nobuhiro
    Kondo, Tadakazu
    Ishikawa, Takayuki
    Watanabe, Mitsumasa
    Kawata, Takahito
    Maeda, Takeshi
    Ueda, Yasunori
    Imada, Kazunori
    Kitano, Toshiyuki
    Tsuji, Masaaki
    Maesako, Yoshitomo
    Oka, Satoko
    Tanaka, Yasuhiro
    Miyoshi, Takashi
    Asagoe, Kosuke
    Itoh, Mitsuru
    Hirata, Hirokazu
    Kawabata, Hiroshi
    Hishizawa, Masakatsu
    Maeda, Akinori
    Yago, Kazuhiro
    Sasaki, Nana
    Uoshima, Nobuhiko
    Ogawa, Seishi
    Takaori-Kondo, Akifumi
    BLOOD, 2023, 142
  • [49] Impact of TP53 Mutated Subclones in Acute Myeloid Leukemia
    Pabst, Gabriel
    Prochazka, Katharina
    Pregartner, Gudrun
    Rucker, Frank G.
    Heitzer, Ellen
    Woelfler, Albert
    Zebisch, Armin
    Berghold, Andrea
    Dohner, Konstanze
    Sill, Heinz
    BLOOD, 2018, 132
  • [50] Outcomes of TP53-mutant acute myeloid leukemia with decitabine and venetoclax
    Kim, Kunhwa
    Maiti, Abhishek
    Loghavi, Sanam
    Pourebrahim, Rasoul
    Kadia, Tapan M.
    Rausch, Caitlin R.
    Furudate, Ken
    Daver, Naval G.
    Alvarado, Yesid
    Ohanian, Maro
    Sasaki, Koji
    Short, Nicholas J.
    Takahashi, Koichi
    Yilmaz, Musa
    Tang, Guilin
    Ravandi, Farhad
    Kantarjian, Hagop M.
    DiNardo, Courtney D.
    Konopleva, Marina Y.
    CANCER, 2021, 127 (20) : 3772 - 3781